|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/22 Lilium N.V. 6-K 6/30/22 77:7M Toppan Merrill/FA2 |
Document/Exhibit Description Pages Size
1: 6-K Current, Quarterly or Annual Report by a Foreign HTML 128K
Issuer
2: EX-99.1 Miscellaneous Exhibit HTML 1.11M
3: EX-99.2 Miscellaneous Exhibit HTML 135K
9: R1 Document and Entity Information HTML 35K
10: R2 Interim Condensed Consolidated Statements of HTML 89K
Operations and Other Comprehensive Income (Loss)
11: R3 Interim Condensed Consolidated Statement of HTML 103K
Financial Position
12: R4 Interim Condensed Consolidated Statement of HTML 54K
Changes in Shareholders' Equity
13: R5 Interim Condensed Consolidated Statement of Cash HTML 101K
Flows
14: R6 Corporate Information HTML 57K
15: R7 Basis of Preparation and Changes to the Groups HTML 26K
Accounting Policies
16: R8 Significant Accounting Judgments, Estimates and HTML 26K
Assumptions
17: R9 COVID 19 Risks and Uncertainties HTML 25K
18: R10 War in Ukraine HTML 23K
19: R11 Going Concern HTML 25K
20: R12 Research and Development Expenses HTML 24K
21: R13 General and Administrative Expenses HTML 24K
22: R14 Selling Expenses HTML 23K
23: R15 Financial Result HTML 37K
24: R16 Income Taxes HTML 24K
25: R17 Property, Plant and Equipment HTML 36K
26: R18 Investment in a Joint Venture / Associate HTML 30K
27: R19 Other Financial Assets HTML 24K
28: R20 Non-Financial Assets HTML 35K
29: R21 Shareholders' Equity HTML 80K
30: R22 Share-based Payments HTML 250K
31: R23 Warrants And Other Financial Liabilities HTML 31K
32: R24 Additional Disclosures on Financial Instruments HTML 74K
33: R25 Commitments and Contingencies HTML 26K
34: R26 Related Party Disclosures HTML 42K
35: R27 Events after the Reporting Period HTML 25K
36: R28 Basis of Preparation and Changes to the Groups HTML 25K
Accounting Policies (Policies)
37: R29 Corporate Information (Tables) HTML 54K
38: R30 Financial Result (Tables) HTML 36K
39: R31 Property, Plant and Equipment (Tables) HTML 34K
40: R32 Investment in a Joint Venture / Associate (Tables) HTML 27K
41: R33 Non-Financial Assets (Tables) HTML 34K
42: R34 Shareholders' Equity (Tables) HTML 73K
43: R35 Share-based Payments (Tables) HTML 255K
44: R36 Warrants And Other Financial Liabilities (Tables) HTML 31K
45: R37 Additional Disclosures on Financial Instruments HTML 73K
(Tables)
46: R38 Related Party Disclosures (Tables) HTML 35K
47: R39 Corporate Information (Details) HTML 40K
48: R40 Going Concern (Details) HTML 23K
49: R41 Research and Development Expenses (Details) HTML 37K
50: R42 General and Administrative Expenses (Details) HTML 35K
51: R43 Selling Expenses (Details) HTML 28K
52: R44 Financial Result (Details) HTML 39K
53: R45 Financial Result - Additional Information HTML 31K
(Details)
54: R46 Income Taxes (Details) HTML 25K
55: R47 Property, Plant and Equipment - Acquired assets HTML 36K
(Details)
56: R48 Property, Plant and Equipment - Additional HTML 27K
informations (Details)
57: R49 Investment in a Joint Venture / Associate HTML 32K
(Details)
58: R50 Investment in a Joint Venture / Associate - HTML 30K
Valuation of investment in Zenlabs (Details)
59: R51 Other Financial Assets (Details) HTML 37K
60: R52 Non-Financial Assets (Details) HTML 39K
61: R53 Shareholders' Equity (Details) HTML 62K
62: R54 Shareholders' Equity - Additional information HTML 88K
(Details)
63: R55 Share-based Payments - Other plans (Details) HTML 44K
64: R56 Share-based Payments - Expense recognized for HTML 127K
participant services (Details)
65: R57 Share-based Payments - Measurement of fair values HTML 102K
(Details)
66: R58 Warrants and Other Financial Liabilities (Details) HTML 30K
67: R59 Additional Disclosures on Financial Instruments - HTML 44K
Financial assets, by class (Details)
68: R60 Additional Disclosures on Financial Instruments - HTML 39K
Financial liabilities, by class (Details)
69: R61 Commitments and Contingencies (Details) HTML 41K
70: R62 Related Party Disclosures - Annual remuneration HTML 44K
and related compensation costs recognized as
expense (Details)
71: R63 Related Party Disclosures - Additional Information HTML 72K
(Details)
72: R64 Events after the Reporting Period (Details) HTML 41K
75: XML IDEA XML File -- Filing Summary XML 142K
73: XML XBRL Instance -- lilm-20220630x6k_htm XML 1.74M
74: EXCEL IDEA Workbook of Financial Reports XLSX 123K
5: EX-101.CAL XBRL Calculations -- lilm-20220630_cal XML 165K
6: EX-101.DEF XBRL Definitions -- lilm-20220630_def XML 637K
7: EX-101.LAB XBRL Labels -- lilm-20220630_lab XML 1.37M
8: EX-101.PRE XBRL Presentations -- lilm-20220630_pre XML 932K
4: EX-101.SCH XBRL Schema -- lilm-20220630 XSD 260K
76: JSON XBRL Instance as JSON Data -- MetaLinks 325± 492K
77: ZIP XBRL Zipped Folder -- 0001410578-22-002819-xbrl Zip 298K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of September, 2022.
Commission File Number 001-40736
i Lilium N.V.
(Translation of registrant’s name into English)
Claude Dornier Straße 1
Bldg. 335, 82234
Wessling, Germany
Telephone: +49 160 9704 6857
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1): ____
Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): ____
CONTENTS
Explanatory Note
On September 28, 2022, Lilium N.V. (the “Company”) issued (i) its Unaudited Condensed Interim Financial Statements as of and for the six months ended June 30, 2022 and (ii) its Management’s Discussion & Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2022, which are furnished as Exhibits 99.1 and 99.2 to this Report on Form 6-K, respectively.
Incorporation by Reference
The contents of this Report on Form 6-K, including Exhibits 99.1 and 99.2, are hereby incorporated by reference into the Company’s registration statement on Form S-8 filed with the Securities and Exchange Commission on November 18, 2021 (File No. 333-261175).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: September 28, 2022 | Lilium N.V. | |
| ||
| By: | /s/ Daniel Wiegand |
| Name: Daniel Wiegand | |
| Title: Chief Executive Officer and Executive Director | |
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/28/22 | |||
| For Period end: | 6/30/22 | |||
| 11/18/21 | S-8 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/17/23 Lilium N.V. 424B2 1:811K Toppan Merrill/FA 7/13/23 Lilium N.V. 424B5 1:812K Toppan Merrill/FA 2/15/23 Lilium N.V. 424B3 1:491K Toppan Merrill/FA 2/03/23 Lilium N.V. F-3 7:800K Toppan Merrill/FA 12/13/22 Lilium N.V. 424B3 1:645K Toppan Merrill/FA 12/12/22 Lilium N.V. F-3/A 3:801K Toppan Merrill/FA 11/25/22 Lilium N.V. F-3 8:987K Toppan Merrill/FA 11/22/22 Lilium N.V. 424B2 1:820K Toppan Merrill/FA 11/18/22 Lilium N.V. 424B5 1:821K Toppan Merrill/FA 10/12/22 Lilium N.V. 424B3 1:471K Toppan Merrill/FA 10/12/22 Lilium N.V. 424B3 1:678K Toppan Merrill/FA 10/03/22 Lilium N.V. POS AM 3:587K Toppan Merrill/FA 10/03/22 Lilium N.V. F-3 5:459K Toppan Merrill/FA 10/03/22 Lilium N.V. F-3 8:1M Toppan Merrill/FA |